Weighted Average Number of Shares Outstanding, Basic of NEXIEN BIOPHARMA, INC. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NEXIEN BIOPHARMA, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • NEXIEN BIOPHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2025 was 70,772,196, a 6.6% increase year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 66,193,840, a 6.2% increase from 2023.
  • NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 62,333,322, a 7.7% increase from 2022.
  • NEXIEN BIOPHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 57,860,108, a 4.4% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 70,772,196 +4,387,912 +6.6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 70,765,603 +5,658,242 +8.7% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q3 2024 70,472,196 +5,897,802 +9.1% 01 Jul 2024 30 Sep 2024 10-Q 18 Nov 2024 2025 Q1
Q2 2024 66,193,840 +3,860,518 +6.2% 01 Apr 2024 30 Jun 2024 10-K 22 Oct 2024 2024 FY
Q1 2024 66,384,284 +3,746,919 +6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q3
Q4 2023 65,107,361 +3,192,308 +5.2% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q2
Q3 2023 64,574,394 +3,500,000 +5.7% 01 Jul 2023 30 Sep 2023 10-Q 18 Nov 2024 2025 Q1
Q2 2023 62,333,322 +4,473,214 +7.7% 01 Apr 2023 30 Jun 2023 10-K 22 Oct 2024 2024 FY
Q1 2023 62,637,365 +3,556,836 +6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q3
Q4 2022 61,915,053 +5,703,297 +10% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024 2024 Q2
Q3 2022 61,074,394 +5,302,198 +9.5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 57,860,108 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 59,080,529 +3,853,086 +7% 01 Jan 2022 31 Mar 2022 10-Q 17 May 2023 2023 Q3
Q4 2021 56,211,756 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023 2023 Q2
Q3 2021 55,772,196 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q1 2021 55,227,443 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q3

NEXIEN BIOPHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 66,193,840 +3,860,518 +6.2% 01 Jul 2023 30 Jun 2024 10-K 22 Oct 2024 2024 FY
2023 62,333,322 +4,473,214 +7.7% 01 Jul 2022 30 Jun 2023 10-K 22 Oct 2024 2024 FY
2022 57,860,108 +2,460,465 +4.4% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023 2023 FY
2021 55,399,643 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.